RecruitingNCT06224023
Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Sponsor
Carol Davila University of Medicine and Pharmacy
Enrollment
30 participants
Start Date
Aug 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Determination of presepsin levels in ascites for people with ascites hepatic, cirrhosis, liver, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTDetermination of presepsin levels in ascites
A diagnostic paracentesis will be performed and presepsin level will be determined in ascites.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06224023
Related Trials
QOL and Sarcopenia in Patients With Ascites
NCT057267471 location
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
NCT0461752215 locations
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
NCT0583222913 locations
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NCT061362212 locations
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
NCT069507881 location